← Back to Fortis Healthcare Ltd. overview
Fortis Healthcare Ltd. — 10-Year Financials
Annual P&L, balance sheet, and key ratios from public BSE/NSE filings.
| Period | Revenue | Net Profit | EPS (₹) | Total Assets | Shareholder Equity | ROE (%) | ROCE (%) | D/E | Net Margin (%) |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹7,724 cr | ₹774 cr | ₹10.26 | ₹13,692 cr | ₹8,917 cr | 8.68% | 10.2% | 0.28x | 10.02% |
| FY2024 | ₹6,835 cr | ₹599 cr | ₹7.93 | ₹13,289 cr | ₹7,663 cr | 7.82% | 10.96% | 0.15x | 8.76% |
| FY2023 | ₹6,213 cr | ₹589 cr | ₹7.8 | ₹12,434 cr | ₹7,242 cr | 8.13% | 11.29% | 0.13x | 9.48% |
| FY2022 | ₹5,639 cr | ₹555 cr | ₹7.35 | ₹11,885 cr | ₹6,178 cr | 8.99% | 15% | 0.2x | 9.84% |
Revenue: Total income from operations (₹ crore).
EPS: Earnings per share (₹), basic.
ROE: Net profit / average shareholder equity.
ROCE: EBIT / capital employed.
D/E: Total debt / shareholder equity.
Net Margin: Net profit as a % of revenue.
All figures sourced from public BSE/NSE filings. Ratios are pre-computed estimates and may differ from primary filings due to rounding.
Educational content — not investment adviceAll financial data is sourced from public filings and shown here for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing on this page constitutes a recommendation or solicitation to transact in any security. All data is at least 90 days old. Past performance is not indicative of future results.